Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 346,103 |
|
|||||
| News | - | ||||||
| Day High | 54.89 | Low High |
|||||
| Day Low | 52.22 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Apogee Therapeutics Inc | APGE | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 1.99 | 3.81% | 54.19 | 18:40:42 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 53.79 | 52.22 | 54.89 | 54.19 | 52.20 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,131 | 346,103 | US$ 53.84 | US$ 18,633,019 | - | 14.19 - 72.29 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:30:19 | 1 | US$ 53.33 | USD |
Apogee Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.75B | 50.66M | - | 0 | -83.99M | -1.66 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Apogee Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APGE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 46.17 | 54.89 | 44.52 | 50.24 | 320,645 | 8.02 | 17.37% |
| 1 Month | 58.37 | 60.02 | 43.605 | 51.74 | 374,432 | -4.18 | -7.16% |
| 3 Months | 37.33 | 72.29 | 33.14 | 57.65 | 729,293 | 16.86 | 45.16% |
| 6 Months | 19.01 | 72.29 | 14.19 | 46.98 | 513,591 | 35.18 | 185.06% |
| 1 Year | 21.50 | 72.29 | 14.19 | 39.32 | 443,251 | 32.69 | 152.05% |
| 3 Years | 21.50 | 72.29 | 14.19 | 39.32 | 443,251 | 32.69 | 152.05% |
| 5 Years | 21.50 | 72.29 | 14.19 | 39.32 | 443,251 | 32.69 | 152.05% |
Apogee Therapeutics Description
| Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts. |
